Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma-Reference-Cited by-同舟云学术

Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma

Published:2001-10 Issue:4 Volume:92 Page:420-423
ISSN:1079-2104
Container-title:Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
language:en
Short-container-title:Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology

Author:

Dahllöf Göran,Borgström Per,Lundell Göran,Jacobsson Hans,Kogner Per

Publisher

Elsevier BV

Subject

General Dentistry,Otorhinolaryngology,Oral Surgery,Surgery

Reference28 articles.

1. Tumors of the sympathetic nervous system: neuroblastoma, ganglioneuroma and phaeochromocytoma;Voute,1992

2. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma;De Kraker;Eur J Cancer,1995

3. Specific uptake of m-[125I] iodobenzyl-guanidine in the human neuroblastoma cell line SK-N-SH;Buck;Cancer Res,1985

4. Summary, conclusions, and future directions of (131I)metaiodo-benzylguanidine therapy in the treatment of neural crest tumours;Shapiro;J Nucl Biol Med,1991

5. Phase I/II study of iodine 131 metaiodobenzyl-guanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation;Lashford;J Clin Oncol,1992

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular radionuclide therapy-induced salivary gland toxicity: an unappreciated threat to patients’ quality of life?;Nuclear Medicine Communications;2024-04-05

2. 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors;Klinische Pädiatrie;2017-05

3. Preclinical Assessment of Strategies for Enhancement of Metaiodobenzylguanidine Therapy of Neuroendocrine Tumors;Seminars in Nuclear Medicine;2011-09

4. Potential Utility of Radioprotective Agents in the Practice of Nuclear Medicine;Cancer Biotherapy and Radiopharmaceuticals;2009-12

5. Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergy;Nuclear Medicine and Biology;2008-08